These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32052239)

  • 1. Orodispersible films as a personalized dosage form for nursing home residents, an exploratory study.
    Visser JC; Wibier L; Mekhaeil M; Woerdenbag HJ; Taxis K
    Int J Clin Pharm; 2020 Apr; 42(2):436-444. PubMed ID: 32052239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orodispersible Films for Compounding Pharmacies.
    Ferreira AO; Brandão MAF; Raposo FJ; Polonini HC; Raposo NRB
    Int J Pharm Compd; 2017; 21(6):454-461. PubMed ID: 29220334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films.
    Visser JC; Wibier L; Kiefer O; Orlu M; Breitkreutz J; Woerdenbag HJ; Taxis K
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32079184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
    Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
    Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oromucosal film preparations: points to consider for patient centricity and manufacturing processes.
    Krampe R; Visser JC; Frijlink HW; Breitkreutz J; Woerdenbag HJ; Preis M
    Expert Opin Drug Deliv; 2016; 13(4):493-506. PubMed ID: 26559519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
    Foo WC; Khong YM; Gokhale R; Chan SY
    Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategies for the formulation and processing of poorly water-soluble drugs.
    Göke K; Lorenz T; Repanas A; Schneider F; Steiner D; Baumann K; Bunjes H; Dietzel A; Finke JH; Glasmacher B; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():40-56. PubMed ID: 28532676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOFTs - Structured orodispersible film templates.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the production methods of orodispersible films.
    Musazzi UM; Khalid GM; Selmin F; Minghetti P; Cilurzo F
    Int J Pharm; 2020 Feb; 576():118963. PubMed ID: 31857185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Oral Cavity Model for Screening the Disintegration Behavior of Orodispersible Films: A Bespoke Design.
    Redfearn A; Scarpa M; Orlu M; Hanson B
    J Pharm Sci; 2019 May; 108(5):1831-1836. PubMed ID: 30639737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
    El-Bary AA; Al Sharabi I; Haza'a BS
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
    Cupone IE; Dellera E; Marra F; Giori AM
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films.
    Borges AF; Silva C; Coelho JF; Simões S
    Pharm Dev Technol; 2017 Mar; 22(2):237-245. PubMed ID: 27346557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
    Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
    Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():149-158. PubMed ID: 28414191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical strength test for orodispersible and buccal films.
    Preis M; Knop K; Breitkreutz J
    Int J Pharm; 2014 Jan; 461(1-2):22-9. PubMed ID: 24291075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orodispersible films and tablets with prednisolone microparticles.
    Brniak W; Maślak E; Jachowicz R
    Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of dysphagia among nursing home residents in eastern China: a cross-sectional study.
    Chen S; Cui Y; Ding Y; Sun C; Xing Y; Zhou R; Liu G
    BMC Geriatr; 2020 Sep; 20(1):352. PubMed ID: 32943011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.